VAREX IMAGING (VREX)
(Delayed Data from NSDQ)
$11.42 USD
+0.19 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $11.38 -0.04 (-0.35%) 5:42 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.42 USD
+0.19 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $11.38 -0.04 (-0.35%) 5:42 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Zacks News
ResMed (RMD)-Backed Landmark ALASKA Study Favors PAP Therapy
by Zacks Equity Research
A late-breaking abstract from ResMed (RMD) supported landmark ALASKA study reported that treatment with PAP therapy improves the likelihood of longevity in sleep apnea patients
Smith+Nephew (SNN) Releases New Features for Hip Arthroplasty
by Zacks Equity Research
Smith+Nephew (SNN) introduced the RI.HIP NAVIGATION software on the CORI Surgical System and announced the commercial availability of RI.INSIGHTS at the AAOS 2021 Annual Meeting.
Earnings Estimates Moving Higher for VAREX IMAGING (VREX): Time to Buy?
by Zacks Equity Research
VAREX IMAGING (VREX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why You Should Retain Haemonetics (HAE) Stock for Now
by Zacks Equity Research
Strong recovery across businesses and strength in plasma franchise benefited Haemonetics (HAE) during the first quarter of fiscal 2022.
Zimmer Biomet's (ZBH) Data Favors mymobility with Apple Watch
by Zacks Equity Research
Zimmer Biomet (ZBH) presented four data presentations backing the mymobility with Apple Watch platform at the AAOS 2021 Annual Meeting.
The Zacks Analyst Blog Highlights: Varex Imaging, Omnicell, STAAR Surgical and IDEXX Laboratories
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Varex Imaging, Omnicell, STAAR Surgical and IDEXX Laboratories
4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip
by Urmimala Biswas
Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.
Cardiovascular Systems (CSII) Introduces Diamondback in Canada
by Zacks Equity Research
The introduction of Cardiovascular Systems' (CSII) Diamondback 360 Coronary OAS in Canada will offer physicians an effective treatment option for patients with coronary artery diseases.
Medtronic (MDT) Receives FDA Nod for Evolut FX TAVR System
by Zacks Equity Research
Medtronic's (MDT) Evolut FX TAVR system offers hemodynamic and durability benefits of the Evolut platform with new product and procedure enhancements.
Zimmer Biomet (ZBH) Receives FDA Nod for ROSA Hip System
by Zacks Equity Research
The recent FDA go-ahead for Zimmer Biomet's (ZBH) ROSA Hip System will aid surgeons perform robotically-assisted direct anterior total hip replacement surgery.
Hill-Rom (HRC) PSS Growth Solid Despite Tough Y/Y Comparison
by Zacks Equity Research
Hill-Rom's (HRC) recent launches, including the Helion Integrated Surgical System in the United States, buoy optimism.
Abbott (ABT) Receives FDA Nod for Amplatzer Amulet Device
by Zacks Equity Research
The FDA's go-ahead for Abbott's (ABT) Amulet will offer a unique treatment option in the United States that seals off the left atrial appendage entirely without any blood-thinning drugs.
Bio-Rad (BIO) Hits a New 52-Week High: What's Driving It?
by Zacks Equity Research
Strong performance across the Life Science and Clinical Diagnostics businesses drove the top line for Bio-Rad (BIO).
Quest Diagnostics (DGX), eMed Deal to Boost BinaxNOW Sales
by Zacks Equity Research
Under the collaboration, eMed's Certified Guide will supervise Quest Diagnostics' (DGX) BinaxNOW home testing process virtually.
Here's Why You Should Retain Neogen (NEOG) Stock for Now
by Zacks Equity Research
Strong fiscal fourth-quarter performance in the Food Safety and Animal Safety segments drove the top line for Neogen (NEOG).
VAREX IMAGING (VREX) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
VAREX IMAGING (VREX) delivered earnings and revenue surprises of 48.15% and 2.95%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
VAREX IMAGING (VREX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
VAREX IMAGING (VREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
VAREX IMAGING (VREX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
VAREX IMAGING (VREX) delivered earnings and revenue surprises of 94.44% and 8.25%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Varex Imaging, Steel Dynamics, EnPro Industries, Dropbox and National Energy
by Zacks Equity Research
Zacks.com featured highlights include: Varex Imaging, Steel Dynamics, EnPro Industries, Dropbox and National Energy
5 Top Stocks to Buy for Superb Earnings Acceleration
by Tirthankar Chakraborty
Steel Dynamics (STLD), EnPro Industries (NPO) & Dropbox (DBX) are a few stocks for which the last two quarter-over-quarter percentage EPS growth rates exceeded the growth rates of the previous periods.
Varex Imaging's (VREX) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Varex Imaging (VREX).
VAREX IMAGING (VREX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
VAREX IMAGING (VREX) delivered earnings and revenue surprises of 300.00% and 2.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate VAREX IMAGING (VREX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
VAREX IMAGING (VREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Keep These 4 Toxic Stocks Away From Your Portfolio
by Rimmi Singhi
Just like selecting good and undervalued stocks on a regular basis can make you rich, identifying and proactively getting rid of toxic stocks is also crucial to maximizing portfolio returns.
Zacks.com featured highlights include: Aramark, Alteryx, Varex Imaging Corp and Cameco Corp
by Zacks Equity Research
Zacks.com featured highlights include: Aramark, Alteryx, Varex Imaging Corp and Cameco Corp